Go here to see the original: Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Go here to see the original: Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more: Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist...
Follow this link: Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus...
View original post here: Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
See the rest here: New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of...
View original post here: Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients
Go here to read the rest: Kane Biotech Announces First Quarter 2024 Financial Results
Excerpt from: Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
See the original post: Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
Read the rest here: Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Recent Comments